← Back to portfolio Porfolio / Arcinova

Arcinova

Pharmaceutical research and development company

Company overview

Arcinova is a Contract Research and Development Organisation (CRDO), providing a comprehensive range of integrated specialist services, spearheading the use of new technology processes to support the development of pioneering drugs for the treatment of life-threatening illnesses.

Website

arcinova.uk

This is an exciting time for Arcinova. We have a fantastic team, a world-class facility and strong market opportunity. We selected BGF because of its long-term approach to investing, and its ability to provide additional funding as we embark on a period of capital expenditure and international expansion.

Professor Ian Shott, executive chair

Company information

Head office

Alnwick, Northumberland

CEO

Professor Ian Shott

Chair

BGF office

Leeds

BGF team

Investment date

Jun 2018

Total BGF investment

£5 million

Business funding insights

December 2020 Insights

How to grow your company through acquisition

Gurinder Sunner, head of BGF in the Midlands considers ‘How to grow your company through acquisition’ In its simplest form,…

Business funding Technology

November 2020 Insights

Infrastructure spending is only one part of the solution

The chancellor is right to back an investment-led recovery, but infrastructure is only part of the solution. Business funding is needed too.

Business funding Infrastructure, construction & property services

An entrepreneur plans how to use expansion capital

November 2020 Insights

What is expansion capital and when might I need it?

Expansion capital can be used by entrepreneurs and business owners for a range of purposes, from product development to acquisition finance and more.

Business funding Portfolio